TERMINATION Due to Settlement After Institution of Trial 35 U.S.C. § 317; 37 C.F.R. § 42.74 | Jul 22, 2025 | PAPER | BOARD |
Joint Motion to Terminate | Jul 11, 2025 | PAPER | PATENT OWNER |
Joint Request to File Settlement Agreement as Business Confidential and to Keep It Separate from Patent Files | Jul 11, 2025 | PAPER | PATENT OWNER |
Patent Owner's Eighth Updated Exhibit List | Jul 11, 2025 | PAPER | PATENT OWNER |
Ex. 2282 Confidential Settlement and License Agreement (Underseal) | Jul 11, 2025 | EXHIBIT | PATENT OWNER |
Ex. 3008 Motion to Terminate | Jul 10, 2025 | EXHIBIT | BOARD |
Other: Hearing transcript | Jun 13, 2025 | PAPER | BOARD |
Patent Owner's Demonstratives | May 8, 2025 | PAPER | PATENT OWNER |
Petitioners' Demonstratives | May 8, 2025 | PAPER | PETITIONER |
Joint Stipulation to Modify Schedule for Exchanging Demonstratives | May 2, 2025 | PAPER | PETITIONER |
Order: Setting Oral Argument | Apr 28, 2025 | PAPER | BOARD |
Patent Owner's Sur-Reply | Apr 11, 2025 | PAPER | PATENT OWNER |
Patent Owner's Seventh Updated Exhibit List | Apr 11, 2025 | PAPER | PATENT OWNER |
EX-2279 Deposition of John Galanis, M.D. | Apr 11, 2025 | EXHIBIT | PATENT OWNER |
EX-2280 Deposition of Daniel Gil Ph.D. | Apr 11, 2025 | EXHIBIT | PATENT OWNER |
EX-2281 Deposition of Anthony Masztak | Apr 11, 2025 | EXHIBIT | PATENT OWNER |
Patent Owner's Notice of Deposition of Anthony M. Masztak | Apr 4, 2025 | PAPER | PATENT OWNER |
Panel Change Order | Apr 3, 2025 | PAPER | BOARD |
Petitioners' Motion to Seal | Apr 1, 2025 | PAPER | PETITIONER |
Exhibit 1202 - Masztak CV | Apr 1, 2025 | EXHIBIT | PETITIONER |
Exhibit 1203 - Expert Declaration of Anthony M. Masztak in Support of Petitioners' Reply (Redacted) | Apr 1, 2025 | EXHIBIT | PETITIONER |
Exhibit 1203 - Expert Declaration of Anthony M. Masztak in Support of Petitioners' Reply (Under Seal) | Apr 1, 2025 | EXHIBIT | PETITIONER |
Petitioners' Fifth Updated Exhibit List | Apr 1, 2025 | PAPER | PETITIONER |
Petitioners' Request for Oral Argument | Apr 1, 2025 | PAPER | PETITIONER |
Patent Owner's Request for Oral Hearing | Apr 1, 2025 | PAPER | PATENT OWNER |
E-mail authorizing counsel substitution | Mar 28, 2025 | EXHIBIT | BOARD |
Joint Stipulation to Change Due Date 3 | Mar 28, 2025 | PAPER | PETITIONER |
Patent Owner's Amended Notice of Deposition of John C. Galanis, MD, FACS | Mar 26, 2025 | PAPER | PATENT OWNER |
Patent Owner's Amended Notice of Deposition of Ivan T. Hofmann, C.P.A., C.F.F., C.L.P. | Mar 18, 2025 | PAPER | PATENT OWNER |
Patent Owner's Notice of Deposition of Ivan T. Hofmann, C.P.A., C.F.F., C.L.P. | Mar 6, 2025 | PAPER | PATENT OWNER |
Patent Owner's Notice of Deposition of John C. Galanis, MD, FACS | Mar 6, 2025 | PAPER | PATENT OWNER |
Patent Owner's Objections to Petitioners' Exhibits | Mar 4, 2025 | PAPER | PATENT OWNER |
Petitioners' Motion to Seal | Feb 25, 2025 | PAPER | PETITIONER |
Exhibit 1129 - IPR2022-00142 Noecker Declaration - FILED UNDER SEAL | Feb 25, 2025 | EXHIBIT | PETITIONER |
Exhibit 1162 - 2025.02.25 Declaration of Ivan T. Hofmann - FILED UNDER SEAL | Feb 25, 2025 | EXHIBIT | PETITIONER |
Exhibit 1171 - IPR2022-00142 Declaration of Ivan T. Hofmann - FILED UNDER SEAL | Feb 25, 2025 | EXHIBIT | PETITIONER |
Exhibit 1176 - 2025.01.30 Ferris IPR Deposition Transcript - FILED UNDER SEAL | Feb 25, 2025 | EXHIBIT | PETITIONER |
Exhibit 1188 - 2022.11.02 IPR2022-00142 Ferris Deposition Transcript - FILED UNDER SEAL | Feb 25, 2025 | EXHIBIT | PETITIONER |
Exhibit 1196 - 2024.01.04 Ferris PI Deposition Transcript - FILED UNDER SEAL | Feb 25, 2025 | EXHIBIT | PETITIONER |
Exhibit 1197 - 2025.02.12 Jarosz IPR Deposition Transcript - FILED UNDER SEAL | Feb 25, 2025 | EXHIBIT | PETITIONER |
Exhibit 1198 - IPR2022-00142 Jarosz Declaration - FILED UNDER SEAL | Feb 25, 2025 | EXHIBIT | PETITIONER |
Exhibit 1031 - 2023.12.31 Gil PI Deposition Transcript | Feb 25, 2025 | EXHIBIT | PETITIONER |
Exhibit 1044 - 2025.02.06 Donnenfeld IPR Deposition Transcript | Feb 25, 2025 | EXHIBIT | PETITIONER |
Exhibit 1045 - 2025.02.13 Stamer IPR Deposition Transcript | Feb 25, 2025 | EXHIBIT | PETITIONER |
Exhibit 1047 - 2025.02.19 Noecker IPR Deposition Transcript | Feb 25, 2025 | EXHIBIT | PETITIONER |
Exhibit 1048 - 2025.01.28 Williams IPR Deposition Transcript | Feb 25, 2025 | EXHIBIT | PETITIONER |
Exhibit 1053 - 2022.11.13 IPR2022-00142 Noecker Deposition Transcript | Feb 25, 2025 | EXHIBIT | PETITIONER |
Exhibit 1054 - 2024.01.21 Donnenfeld PI Deposition Transcript | Feb 25, 2025 | EXHIBIT | PETITIONER |
Exhibit 1058 - ARVO Glossary | Feb 25, 2025 | EXHIBIT | PETITIONER |
Exhibit 1059 - Decoding Your Prescriptions: Understanding Pharmacy Abbreviations | Feb 25, 2025 | EXHIBIT | PETITIONER |
Exhibit 1069 - Sklubalova 2005 | Feb 25, 2025 | EXHIBIT | PETITIONER |
Exhibit 1070 - Sklubalova 2006 | Feb 25, 2025 | EXHIBIT | PETITIONER |
Exhibit 1072 - 2024.02.19 Williams PI Deposition Transcript | Feb 25, 2025 | EXHIBIT | PETITIONER |
Petitioners' Reply | Feb 25, 2025 | PAPER | PETITIONER |
Exhibit 1129 - IPR2022-00142 Noecker Declaration - REDACTED | Feb 25, 2025 | EXHIBIT | PETITIONER |
Exhibit 1139 - Ackerman 2019 | Feb 25, 2025 | EXHIBIT | PETITIONER |
Exhibit 1140 - McLaurin 2018 | Feb 25, 2025 | EXHIBIT | PETITIONER |
Exhibit 1141- Torkildsen 2018 | Feb 25, 2025 | EXHIBIT | PETITIONER |
Exhibit 1144 - Hosten | Feb 25, 2025 | EXHIBIT | PETITIONER |
Exhibit 1162 - 2025.02.25 Declaration of Ivan T. Hofmann - REDACTED | Feb 25, 2025 | EXHIBIT | PETITIONER |
Exhibit 1163 - CV of Ivan T. Hofmann | Feb 25, 2025 | EXHIBIT | PETITIONER |
Exhibit 1167 - Lumify Orange Book Patent List | Feb 25, 2025 | EXHIBIT | PETITIONER |
Exhibit 1168 - Patent Assignment for US 11596600 | Feb 25, 2025 | EXHIBIT | PETITIONER |
Exhibit 1169 - Lumify Label | Feb 25, 2025 | EXHIBIT | PETITIONER |
Exhibit 1147 - 2025.02.25 Reply Declaration of John C. Galanis | Feb 25, 2025 | EXHIBIT | PETITIONER |
Exhibit 1170 - DRL Form 20-F for Fiscal Year 2023-2024 | Feb 25, 2025 | EXHIBIT | PETITIONER |
Exhibit 1171 - IPR2022-00142 Declaration of Ivan T. Hofmann - REDACTED | Feb 25, 2025 | EXHIBIT | PETITIONER |
Exhibit 1172 - Bausch Fourth Quarter 2018 Earnings Call Transcript | Feb 25, 2025 | EXHIBIT | PETITIONER |
Exhibit 1173 - Bausch Health 2019 Q2 Earnings Call Transcript | Feb 25, 2025 | EXHIBIT | PETITIONER |
Exhibit 1174 - Bausch Health 2020 Q4 Earnings Call Transcript | Feb 25, 2025 | EXHIBIT | PETITIONER |
Exhibit 1175 - Bausch Health 2021 Q4 Earnings Call Transcript | Feb 25, 2025 | EXHIBIT | PETITIONER |
Exhibit 1177 - Barry’s Find Your Strength | Feb 25, 2025 | EXHIBIT | PETITIONER |
Exhibit 1178 - HG 2019 Muse Creative Awards | Feb 25, 2025 | EXHIBIT | PETITIONER |
Exhibit 1179 - HG Agency | Feb 25, 2025 | EXHIBIT | PETITIONER |
Exhibit 1180 - MUSE Awards | Feb 25, 2025 | EXHIBIT | PETITIONER |
Exhibit 1181 - MUSE Awards 2019 Silver Winner Information | Feb 25, 2025 | EXHIBIT | PETITIONER |
Exhibit 1182 - MUSE Awards 2019 Rose Gold Winner Information | Feb 25, 2025 | EXHIBIT | PETITIONER |
Exhibit 1183 - Wavemaker Global – Two Gold Effies | Feb 25, 2025 | EXHIBIT | PETITIONER |
Exhibit 1184 - Wavemaker Global – Our Work | Feb 25, 2025 | EXHIBIT | PETITIONER |
Exhibit 1185 - Businesswire – Lumify Eye Illuminations | Feb 25, 2025 | EXHIBIT | PETITIONER |
Exhibit 1186 - LumifyEyes – Lumify Eye Illuminations | Feb 25, 2025 | EXHIBIT | PETITIONER |
Exhibit 1187 - FiercePharma – Bausch + Lomb kicks off TikTok Challenge for Lumify | Feb 25, 2025 | EXHIBIT | PETITIONER |
Exhibit 1188 - 2022.11.02 IPR2022-00142 Ferris Deposition Transcript - REDACTED | Feb 25, 2025 | EXHIBIT | PETITIONER |
Exhibit 1189 - PR NewsWire – Bausch + Lomb Launches #LUMIFYEyeDance | Feb 25, 2025 | EXHIBIT | PETITIONER |
Exhibit 1190 - TikTok Lumify Eye Dance (November 2022) | Feb 25, 2025 | EXHIBIT | PETITIONER |
Exhibit 1191 - FTC Disclosures 101 for Social Media Influencers | Feb 25, 2025 | EXHIBIT | PETITIONER |
Exhibit 1192 - TikTok Allanface Video | Feb 25, 2025 | EXHIBIT | PETITIONER |
Exhibit 1193 - TikTok OrionSisters Video | Feb 25, 2025 | EXHIBIT | PETITIONER |
Exhibit 1194 - Bausch + Lomb #LUMIFYEyeDance Challenge Wins 2022 Public Relations | Feb 25, 2025 | EXHIBIT | PETITIONER |
Exhibit 1195 - Event Marketer Coachella 2024 Experimental Marketing | Feb 25, 2025 | EXHIBIT | PETITIONER |
Exhibit 1198 - IPR2022-00142 Jarosz Declaration - REDACTED | Feb 25, 2025 | EXHIBIT | PETITIONER |
Exhibit 1199 - 2022.11.11 IPR2022-00142 Jarosz Deposition Transcript | Feb 25, 2025 | EXHIBIT | PETITIONER |
Exhibit 1200 - Barry’s Instagram | Feb 25, 2025 | EXHIBIT | PETITIONER |
Exhibit 1201 - US Patent No. 9,259,425 | Feb 25, 2025 | EXHIBIT | PETITIONER |
Patent Owner's Updated Mandatory Notices | Feb 21, 2025 | PAPER | PATENT OWNER |
ORDER Denying without Prejudice Petitioner’s Motion for Additional Discovery 37 C.F.R. § 42.51(b)(2)(i) | Feb 13, 2025 | PAPER | BOARD |
Petitioners' Updated Mandatory Notices | Feb 11, 2025 | PAPER | PETITIONER |
ORDER Granting Patent Owner’s Motion for Pro Hac Vice Admission of Matthew J. Luneack 37 C.F.R. § 42.10 | Feb 11, 2025 | PAPER | BOARD |
Ex. 3005 | Jan 30, 2025 | EXHIBIT | BOARD |
Ex. 3006 | Jan 30, 2025 | EXHIBIT | BOARD |
Petitioners' Unopposed Notice of Intent to Designate Provisionally Recognized PTAB Attorney Timothy J. Beavers as Back Up Counsel Under 37 C.F.R. Section 42.10(c) | Jan 29, 2025 | PAPER | PETITIONER |
Exhibit 1038 - Declaration of Timothy J. Beavers in Support of Notice of Intent to Designate Provisionally Recognized PTAB Attorney as Back-Up Counsel Under 37 C.F.R. Section 42.10(c) | Jan 29, 2025 | EXHIBIT | PETITIONER |
Petitioners' Fourth Updated Exhibit List | Jan 29, 2025 | PAPER | PETITIONER |
Patent Owner's Opposition to Petitioners' Motion for Additional Discovery | Jan 29, 2025 | PAPER | PATENT OWNER |
EX-2276 Email chain regarding Depositions | Jan 29, 2025 | EXHIBIT | PATENT OWNER |
EX-2277 Order Granting Motion to Stay | Jan 29, 2025 | EXHIBIT | PATENT OWNER |
EX-2278 Email chain regarding cross use agreement | Jan 29, 2025 | EXHIBIT | PATENT OWNER |
Patent Owner's Sixth Updated Exhibit List | Jan 29, 2025 | PAPER | PATENT OWNER |
Patent Owner's Motion for Admission Pro Hac Vice of Matthew J. Luneack | Jan 27, 2025 | PAPER | PATENT OWNER |
Patent Owner's Fifth Updated Exhibit List | Jan 27, 2025 | PAPER | PATENT OWNER |
EX-2275_Declaration of Matthew J. Luneack in Support of Motion for Admission Pro Hac Vice | Jan 27, 2025 | EXHIBIT | PATENT OWNER |
Petitioners' Notice of Deposition of Robert J. Noecker | Jan 23, 2025 | PAPER | PETITIONER |
Petitioners' Unopposed Notice of Intent to Designate Provisionally Recognized PTAB Attorney Robert Frederickson III as Back Up Counsel Under 37 C.F.R. Section 42.10(c) | Jan 23, 2025 | PAPER | PETITIONER |
Exhibit 1033 - Declaration of Robert Frederickson III in Support of Notice of Intent to Designate Provisionally Recognized PTAB Attorney as Back-Up Counsel Under 37 C.F.R. Section 42.10(c) | Jan 23, 2025 | EXHIBIT | PETITIONER |
Petitioners' Unopposed Notice of Intent to Designate Provisionally Recognized PTAB Attorney Elaine Blais as Back Up Counsel Under 37 C.F.R. Section 42.10(c) | Jan 23, 2025 | PAPER | PETITIONER |
Exhibit 1036 - Declaration of Elaine H. Blais in Support of Notice of Intent to Designate Provisionally Recognized PTAB Attorney as Back-Up Counsel Under 37 C.F.R. Section 42.10(c) | Jan 23, 2025 | EXHIBIT | PETITIONER |
Petitioners' Third Updated Exhibit List | Jan 23, 2025 | PAPER | PETITIONER |
Ex. 3004 | Jan 22, 2025 | EXHIBIT | BOARD |
Petitioners' Motion for Additional Discovery | Jan 22, 2025 | PAPER | PETITIONER |
Exhibit 1039 - District Court Protective Order | Jan 22, 2025 | EXHIBIT | PETITIONER |
Petitioners' Second Updated Exhibit List | Jan 22, 2025 | PAPER | PETITIONER |
Exhibit 3003 | Jan 14, 2025 | EXHIBIT | BOARD |
Petitioners' Notice of Deposition of Dr. Daniel Gil | Jan 14, 2025 | PAPER | PETITIONER |
Petitioners' Notice of Deposition of Dr. Eric Donnenfeld | Jan 14, 2025 | PAPER | PETITIONER |
Petitioners' Notice of Deposition of Dr. Robert Williams III | Jan 14, 2025 | PAPER | PETITIONER |
Petitioners' Notice of Deposition of Dr. W. Daniel Stamer | Jan 14, 2025 | PAPER | PETITIONER |
Petitioners' Notice of Deposition of John Ferris | Jan 14, 2025 | PAPER | PETITIONER |
Petitioners' Notice of Deposition of John Jarosz | Jan 14, 2025 | PAPER | PETITIONER |
Petitioners' Notice of Deposition of Kurt R. Karst | Jan 14, 2025 | PAPER | PETITIONER |
Petitioners' Updated Power of Attorney | Jan 10, 2025 | PAPER | PETITIONER |
Petitioners' Updated Mandatory Notices | Jan 10, 2025 | PAPER | PETITIONER |
[Amended] Patent Owner's Response (Under Seal) | Dec 27, 2024 | PAPER | PATENT OWNER |
Red-Line Showing Changes from Original to Amended Patent Owner's Response (Under Seal) | Dec 27, 2024 | PAPER | PATENT OWNER |
[Amended] Patent Owner's Response | Dec 27, 2024 | PAPER | PATENT OWNER |
Patent Owner's Fourth Updated Exhibit List | Dec 27, 2024 | PAPER | PATENT OWNER |
EX-2271 Plaintiffs' Opening Markman Brief (Amended) | Dec 27, 2024 | EXHIBIT | PATENT OWNER |
Exhibit 3002 | Dec 26, 2024 | EXHIBIT | BOARD |
Petitioners' Objections to Patent Owner's Evidence Submitted with Patent Owner's Response | Dec 10, 2024 | PAPER | PETITIONER |
EX-2148 (2017 Annual Report) | Dec 3, 2024 | EXHIBIT | PATENT OWNER |
EX-2149 (2018 Annual Report) | Dec 3, 2024 | EXHIBIT | PATENT OWNER |
EX-2150 (2019 Q1 Presentation) | Dec 3, 2024 | EXHIBIT | PATENT OWNER |
EX-2152 (J&J 2006 10K) | Dec 3, 2024 | EXHIBIT | PATENT OWNER |
EX-2153 (accessdata.fda.gov NDA 020065 products) | Dec 3, 2024 | EXHIBIT | PATENT OWNER |
EX-2154 (accessdata.fda.gov approved drugs) | Dec 3, 2024 | EXHIBIT | PATENT OWNER |
EX-2155 (accessdata.fda.gov NDA 020485 products) | Dec 3, 2024 | EXHIBIT | PATENT OWNER |
EX-2156 (amazon.com Lumify) | Dec 3, 2024 | EXHIBIT | PATENT OWNER |
EX-2157 (bausch.com locations) | Dec 3, 2024 | EXHIBIT | PATENT OWNER |
EX-2158 (bausch.com BLCO ticker) | Dec 3, 2024 | EXHIBIT | PATENT OWNER |
EX-2159 (bausch.com redness relief) | Dec 3, 2024 | EXHIBIT | PATENT OWNER |
EX-2160 (businesswire.com) | Dec 3, 2024 | EXHIBIT | PATENT OWNER |
EX-2161 (cleareyes.com all redness relief) | Dec 3, 2024 | EXHIBIT | PATENT OWNER |
EX-2162 (cleareyes.com Complete Sensitive) | Dec 3, 2024 | EXHIBIT | PATENT OWNER |
EX-2163 (cleareyes.com Cooling) | Dec 3, 2024 | EXHIBIT | PATENT OWNER |
EX-2164 (cleareyes.com Max) | Dec 3, 2024 | EXHIBIT | PATENT OWNER |
EX-2165 (cleareyes.com Directions) | Dec 3, 2024 | EXHIBIT | PATENT OWNER |
EX-2166 (cleareyes.com Redness Relief) | Dec 3, 2024 | EXHIBIT | PATENT OWNER |
EX-2167 2024.11.17 - cvs.com - Drops & Lubricants | Dec 3, 2024 | EXHIBIT | PATENT OWNER |
EX-2168 (cvs.com Lumify) | Dec 3, 2024 | EXHIBIT | PATENT OWNER |
EX-2169 (DailyMed Rohto Cool) updated | Dec 3, 2024 | EXHIBIT | PATENT OWNER |
EX-2170 (DailyMed Visine) | Dec 3, 2024 | EXHIBIT | PATENT OWNER |
EX-2171 (eyewire.news) | Dec 3, 2024 | EXHIBIT | PATENT OWNER |
EX-2172 (fda.report Bausch filings) | Dec 3, 2024 | EXHIBIT | PATENT OWNER |
EX-2173 (fda.report Prestige filings) | Dec 3, 2024 | EXHIBIT | PATENT OWNER |
EX-2176 (ir.bauschhealth.com Lumify launch) | Dec 3, 2024 | EXHIBIT | PATENT OWNER |
EX-2177 (ir.bauschhealth.com Lumify approval) | Dec 3, 2024 | EXHIBIT | PATENT OWNER |
EX-2178 (ir.bauschhealth.com name change) | Dec 3, 2024 | EXHIBIT | PATENT OWNER |
EX-2179 (ir.nielsen.com) | Dec 3, 2024 | EXHIBIT | PATENT OWNER |
EX-2180 (lumifydrops.com FAQ) | Dec 3, 2024 | EXHIBIT | PATENT OWNER |
EX-2181 (lumifydrops.com clinical info) | Dec 3, 2024 | EXHIBIT | PATENT OWNER |
EX-2182 (lumifydrops.com science) | Dec 3, 2024 | EXHIBIT | PATENT OWNER |
EX-2183 (mckinsey.com) | Dec 3, 2024 | EXHIBIT | PATENT OWNER |
EX-2184 (opthalmologyweb.com) | Dec 3, 2024 | EXHIBIT | PATENT OWNER |
EX-2185 2024.11.15-optometricmanagment.com-How to Maximize | Dec 3, 2024 | EXHIBIT | PATENT OWNER |
EX-2186 (optometrytimes.com) | Dec 3, 2024 | EXHIBIT | PATENT OWNER |
EX-2187 2024.11.15-patents.bausch.com-Bausch Patents | Dec 3, 2024 | EXHIBIT | PATENT OWNER |
EX-2188 (pi.bausch.com drug facts) | Dec 3, 2024 | EXHIBIT | PATENT OWNER |
EX-2189 (pi.bausch.com max drug facts) | Dec 3, 2024 | EXHIBIT | PATENT OWNER |
EX-2190 pitchbook.com | Dec 3, 2024 | EXHIBIT | PATENT OWNER |
EX-2037 Debbasch 2000 | Dec 3, 2024 | EXHIBIT | PATENT OWNER |
EX-2036 Alphagan P (0.1%) Approval Letter 2005 | Dec 3, 2024 | EXHIBIT | PATENT OWNER |
EX-2038 Pisella 2002 | Dec 3, 2024 | EXHIBIT | PATENT OWNER |
EX-2039 Madhu | Dec 3, 2024 | EXHIBIT | PATENT OWNER |
EX-2040 245 IPR Laskar Depo Transcript | Dec 3, 2024 | EXHIBIT | PATENT OWNER |
EX-2041 Allergan v. Sandoz 14-275 opinion | Dec 3, 2024 | EXHIBIT | PATENT OWNER |
EX-2042 Noecker 2001 | Dec 3, 2024 | EXHIBIT | PATENT OWNER |
EX-2043 Drugs@FDA - Alphagan P 0.15% | Dec 3, 2024 | EXHIBIT | PATENT OWNER |
EX-2044 Drugs@FDA FDA Drug Details, Acular Perservative Free | Dec 3, 2024 | EXHIBIT | PATENT OWNER |
EX-2045 FDA Approves Preservative-Free Drug to Treat Glaucoma | Dec 3, 2024 | EXHIBIT | PATENT OWNER |
EX-2046 NDA 208144, Section 2.3.P.1.1 (Public) | Dec 3, 2024 | EXHIBIT | PATENT OWNER |
EX-2047 Alphagan P 0.15% Chemistry Review | Dec 3, 2024 | EXHIBIT | PATENT OWNER |
EX-2048 Alphagan P 0.1% Chemistry Review | Dec 3, 2024 | EXHIBIT | PATENT OWNER |
EX-2049 21 CFR Part 330_Part 1 of 2 | Dec 3, 2024 | EXHIBIT | PATENT OWNER |
EX-2049 21 CFR Part 330_Part 2 of 2 | Dec 3, 2024 | EXHIBIT | PATENT OWNER |
EX-2050 Lumify Labeling | Dec 3, 2024 | EXHIBIT | PATENT OWNER |
EX-2191 (prestigebrands.com) | Dec 3, 2024 | EXHIBIT | PATENT OWNER |
EX-2192 (prnewswire.com Bausch) | Dec 3, 2024 | EXHIBIT | PATENT OWNER |
EX-2193 (prnewswire.com -Nielsen BASES) | Dec 3, 2024 | EXHIBIT | PATENT OWNER |
EX-2194 (reviewofoptometry.com) | Dec 3, 2024 | EXHIBIT | PATENT OWNER |
EX-2195 (riteaid.com redness relief drops) | Dec 3, 2024 | EXHIBIT | PATENT OWNER |
EX-2196 (riteaid.com sterile eye drops) | Dec 3, 2024 | EXHIBIT | PATENT OWNER |
EX-2197 2024.11.15-rohtoeyedrops.com-Rohto All-In-One | Dec 3, 2024 | EXHIBIT | PATENT OWNER |
EX-2198 2024.11.15-rohtoeyedrops.com-Rohto Cool Relief | Dec 3, 2024 | EXHIBIT | PATENT OWNER |
EX-2199 2024.11.15-rohtoeyedrops.com-RohtoMax Strength Redness | Dec 3, 2024 | EXHIBIT | PATENT OWNER |
EX-2200 (rohtoeyedrops.com-Optic Glow) | Dec 3, 2024 | EXHIBIT | PATENT OWNER |
EX-2201 (rohtoeyedrops.com-Digi Eye) | Dec 3, 2024 | EXHIBIT | PATENT OWNER |
EX-2202 (rohtoeyedrops.com-Redness Reliever) | Dec 3, 2024 | EXHIBIT | PATENT OWNER |
EX-2203 (target.com) | Dec 3, 2024 | EXHIBIT | PATENT OWNER |
EX-2205 (us.mentholatum.com) | Dec 3, 2024 | EXHIBIT | PATENT OWNER |
EX-2206 (walgreens.com) | Dec 3, 2024 | EXHIBIT | PATENT OWNER |
EX-2207 (walmart.com) | Dec 3, 2024 | EXHIBIT | PATENT OWNER |
EX-2208 (walrus.com) | Dec 3, 2024 | EXHIBIT | PATENT OWNER |
EX-2209 (accessdata.fda.gov Lumify label) | Dec 3, 2024 | EXHIBIT | PATENT OWNER |
EX-2210 Good Health Can't Wait | Dec 3, 2024 | EXHIBIT | PATENT OWNER |
EX-2211 drreddys.com-Dr. Reddy’s Laboratories–who are we | Dec 3, 2024 | EXHIBIT | PATENT OWNER |
EX-2051 Qoliana Label (2006) | Dec 3, 2024 | EXHIBIT | PATENT OWNER |
EX-2052 (glamour.com) | Dec 3, 2024 | EXHIBIT | PATENT OWNER |
EX-2053 (intothegloss.com) | Dec 3, 2024 | EXHIBIT | PATENT OWNER |
EX-2054 (newyou.com) | Dec 3, 2024 | EXHIBIT | PATENT OWNER |
EX-2055 (prnewswire.com -Nielsen BASES) | Dec 3, 2024 | EXHIBIT | PATENT OWNER |
EX-2056 (thezoereport.com) | Dec 3, 2024 | EXHIBIT | PATENT OWNER |
EX-2057 2018 NACDS Product of the Year | Dec 3, 2024 | EXHIBIT | PATENT OWNER |
EX-2058 2019 April_May BRIDES Best of Beauty Award | Dec 3, 2024 | EXHIBIT | PATENT OWNER |
EX-2212 New-2024.11.17-drreddys.com-contact-us (princeton nj) | Dec 3, 2024 | EXHIBIT | PATENT OWNER |
EX-2213 12.31.2023 10K Bausch Health_NoRestriction | Dec 3, 2024 | EXHIBIT | PATENT OWNER |
EX-2214 Dr. Reddys Product Catalog 2021-2022 | Dec 3, 2024 | EXHIBIT | PATENT OWNER |
EX-2215 New-Lumify FDA Label (2023.05.02) | Dec 3, 2024 | EXHIBIT | PATENT OWNER |
EXPUNGED | Dec 3, 2024 | EXHIBIT | PATENT OWNER |
EX-2217 2q24-bausch-lomb-earnings-presentation | Dec 3, 2024 | EXHIBIT | PATENT OWNER |
EX-2218 New-Bausch and Lomb 2022 10K | Dec 3, 2024 | EXHIBIT | PATENT OWNER |
EX-2219 US Securities and Exchange Commission FORM 10-Q | Dec 3, 2024 | EXHIBIT | PATENT OWNER |
EX-2220 Lumify Drug Label | Dec 3, 2024 | EXHIBIT | PATENT OWNER |
EX-2221 2024.11.17-cnet.com-Best Eye Drops | Dec 3, 2024 | EXHIBIT | PATENT OWNER |
EX-2222 2024.11.17-allaboutvision.com-Eye Drop | Dec 3, 2024 | EXHIBIT | PATENT OWNER |
EX-2224 Declaration of Eric D. Donnenfeld M.D. (600 IPR) | Dec 3, 2024 | EXHIBIT | PATENT OWNER |
EX-2225 Declaration of W. Daniel Stamer (600 IPR) | Dec 3, 2024 | EXHIBIT | PATENT OWNER |
EX-2227 Declaration of Daniel W. Gil Ph.D (600 IPR) | Dec 3, 2024 | EXHIBIT | PATENT OWNER |
EX-2228 Declaration of Kurst R. Karst | Dec 3, 2024 | EXHIBIT | PATENT OWNER |
EX-2230 Declaration of John Ferris (600 Patent - Under Seal) | Dec 3, 2024 | EXHIBIT | PATENT OWNER |
EX-2231 Preliminary Injunction Laskar Depo Transcript | Dec 3, 2024 | EXHIBIT | PATENT OWNER |
EX-2232 Drug Appl Process for Nonprescription Drugs | Dec 3, 2024 | EXHIBIT | PATENT OWNER |
EX-2233 Allergan Press Release (2002) | Dec 3, 2024 | EXHIBIT | PATENT OWNER |
EX-2234 Drugs@FDA - Alphagan P 0.15% | Dec 3, 2024 | EXHIBIT | PATENT OWNER |
EX-2235 (Xiidra Label) | Dec 3, 2024 | EXHIBIT | PATENT OWNER |
EX-2236 (Rhopressa Label) | Dec 3, 2024 | EXHIBIT | PATENT OWNER |
EX-2237 (Vyzulta Label) | Dec 3, 2024 | EXHIBIT | PATENT OWNER |
EX-2238 (Oxervate Label) | Dec 3, 2024 | EXHIBIT | PATENT OWNER |
EX-2239 (Rocklatan Label) | Dec 3, 2024 | EXHIBIT | PATENT OWNER |
EX-2240 (Zerviate Label) | Dec 3, 2024 | EXHIBIT | PATENT OWNER |
EX-2241 (Vuity Label) | Dec 3, 2024 | EXHIBIT | PATENT OWNER |
EX-2242 (Iheezo Label) | Dec 3, 2024 | EXHIBIT | PATENT OWNER |
EX-2243 (Omlonti Label) | Dec 3, 2024 | EXHIBIT | PATENT OWNER |
EX-2244 (Clear Eyes Maximum Itchy Eye Relief Label) | Dec 3, 2024 | EXHIBIT | PATENT OWNER |
EX-2245 Sertkaya 2014 | Dec 3, 2024 | EXHIBIT | PATENT OWNER |
EX-2246 Antiseptic FDA Letters_FDA | Dec 3, 2024 | EXHIBIT | PATENT OWNER |
EX-2247 FDA, Approval Letter, RID MOUSSE (NDA 021043) (Mar. 7, 2000) | Dec 3, 2024 | EXHIBIT | PATENT OWNER |
EX-2248 FDA, Approval Package NDA 208144 (LUMIFY) | Dec 3, 2024 | EXHIBIT | PATENT OWNER |
EX-2249 FDA, Citizen Petition Response (Oct. 14, 2003) | Dec 3, 2024 | EXHIBIT | PATENT OWNER |
EX-2059 2019 NewBeauty Award Winners_ Best Innovations | Dec 3, 2024 | EXHIBIT | PATENT OWNER |
EX-2060 2022 New Beauty Beauty Awards_Never Knew We Needed | Dec 3, 2024 | EXHIBIT | PATENT OWNER |
EX-2061 NewBeauty_Spring2023_Cover & Feature | Dec 3, 2024 | EXHIBIT | PATENT OWNER |
EX-2062 Pookie TOP AMZ Prime Picks | Dec 3, 2024 | EXHIBIT | PATENT OWNER |
EX-2063 LUMIFY September 2024 Business (Public) | Dec 3, 2024 | EXHIBIT | PATENT OWNER |
EX-2064 IQVIA - Claim Substantiation | Dec 3, 2024 | EXHIBIT | PATENT OWNER |
EX-2065 LUMIFY® Redness Reliever Eye Drops _ Bausch + Lomb | Dec 3, 2024 | EXHIBIT | PATENT OWNER |
EX-2067 How LUMIFY Redness Reliever Eye Drops Work Differently test | Dec 3, 2024 | EXHIBIT | PATENT OWNER |
EX-2068 https_www.ipsos.com_en-hk_healthcare | Dec 3, 2024 | EXHIBIT | PATENT OWNER |
EX-2069 Lumify ECP A&U Report 2020 (Public) | Dec 3, 2024 | EXHIBIT | PATENT OWNER |
EX-2070 Lumify ECP A&U Report_Public | Dec 3, 2024 | EXHIBIT | PATENT OWNER |
EX-2071 3q24-bausch-lomb-earnings-presentation | Dec 3, 2024 | EXHIBIT | PATENT OWNER |
EX-2072 Lumify PnL 93024 (Public) | Dec 3, 2024 | EXHIBIT | PATENT OWNER |
EX-2073 4q23-bausch-lomb-earnings-presentation | Dec 3, 2024 | EXHIBIT | PATENT OWNER |
EX-2250 FDA, CPG Sec. 450.300 (1995) | Dec 3, 2024 | EXHIBIT | PATENT OWNER |
EX-2251 FDA, Draft Guid, Appls-Covered-by-Sect-505(b)(2) (1999) | Dec 3, 2024 | EXHIBIT | PATENT OWNER |
EX-2252 FDA, Overview of Issues Jt Nonprescrip Drugs Advisory Comm (2001) | Dec 3, 2024 | EXHIBIT | PATENT OWNER |
EX-2253 FDA, Guid Doc Search (OTC) | Dec 3, 2024 | EXHIBIT | PATENT OWNER |
EX-2254 FDA Guid, Adverse-Reactions-Section-of-Label (2006) | Dec 3, 2024 | EXHIBIT | PATENT OWNER |
EX-2255 FDA Guid, ANDAs-Pharma-Solid-Polymorphism (2007) | Dec 3, 2024 | EXHIBIT | PATENT OWNER |
EX-2256 FDA Guid, Expedited Progs for Serious Conditions (2014) | Dec 3, 2024 | EXHIBIT | PATENT OWNER |
EX-2257 FDA Guid, Innovative-Approaches (2018) | Dec 3, 2024 | EXHIBIT | PATENT OWNER |
EX-2258 FDA Guid, Label-Comprehension-Studies (2010) | Dec 3, 2024 | EXHIBIT | PATENT OWNER |
EX-2259 FDA Guid, Self-Select-Studies (2013) | Dec 3, 2024 | EXHIBIT | PATENT OWNER |
EX-2260 FDA Guid, Time-&-Extent-Applications (2011) | Dec 3, 2024 | EXHIBIT | PATENT OWNER |
EX-2261 FDA, Historical Status of OTC Rulemakings | Dec 3, 2024 | EXHIBIT | PATENT OWNER |
EX-2262 FDA, Labeling for CBER-Regulated Products | Dec 3, 2024 | EXHIBIT | PATENT OWNER |
EX-2263 FDA, MAPP 6020.5 Rev. 2, Good Review Practice | Dec 3, 2024 | EXHIBIT | PATENT OWNER |
EX-2265 FDA, OTC Monograph M018 (2022) | Dec 3, 2024 | EXHIBIT | PATENT OWNER |
EX-2266 FDA, Rulemaking History for OTC Ophthalmic Drug Products | Dec 3, 2024 | EXHIBIT | PATENT OWNER |
EX-2267 FDA, Regulatory Procedures Manual, Chapter 4-Advisory Actions | Dec 3, 2024 | EXHIBIT | PATENT OWNER |
EX-2268 PhRMA, Research and Development Policy Framework | Dec 3, 2024 | EXHIBIT | PATENT OWNER |
EX-2269 CPI Inflation Calculator | Dec 3, 2024 | EXHIBIT | PATENT OWNER |
EX-2271 Plaintiffs' Opening Markman Brief (600 patent) | Dec 3, 2024 | EXHIBIT | PATENT OWNER |
EX-2272 Decl of Dr. Trattler ISO Plaintiffs' Opening Markman (600 patent) | Dec 3, 2024 | EXHIBIT | PATENT OWNER |
EX-2273 Naphcon A Label | Dec 3, 2024 | EXHIBIT | PATENT OWNER |
EX-2274 Visine Original Redness Relief | Dec 3, 2024 | EXHIBIT | PATENT OWNER |
EX-2074 LUMIFY INCREMENTAL TO EYE CARE & RED RELIVERS CAT. (Public) | Dec 3, 2024 | EXHIBIT | PATENT OWNER |
EX-2075 LUMIFY INCREMENTALITY (Public) | Dec 3, 2024 | EXHIBIT | PATENT OWNER |
EX-2076 Circanas Heritage_Uniting IRI & NPDs Market Expertise | Dec 3, 2024 | EXHIBIT | PATENT OWNER |
EX-2077 LUMIFY LEGAL DATA OCTOBER 2024 (Public) | Dec 3, 2024 | EXHIBIT | PATENT OWNER |
EX-2078 LUMIFY LEGAL DATA POS OCTOBER 2024 format_Public | Dec 3, 2024 | EXHIBIT | PATENT OWNER |
EX-2081 Huang | Dec 3, 2024 | EXHIBIT | PATENT OWNER |
EX-2082 Doshi | Dec 3, 2024 | EXHIBIT | PATENT OWNER |
EX-2083 Picture of an Eye | Dec 3, 2024 | EXHIBIT | PATENT OWNER |
EX-2084 Middleton Auvelity | Dec 3, 2024 | EXHIBIT | PATENT OWNER |
EX-2085 IPR Depo Tr. Galanis, M.D., FACS, John - Mini | Dec 3, 2024 | EXHIBIT | PATENT OWNER |
EX-2086 Yassen 2007 | Dec 3, 2024 | EXHIBIT | PATENT OWNER |
EX-2087 Pandit 2007 | Dec 3, 2024 | EXHIBIT | PATENT OWNER |
EX-2088 Rowland 1995 | Dec 3, 2024 | EXHIBIT | PATENT OWNER |
EX-2089 Lee 2017 | Dec 3, 2024 | EXHIBIT | PATENT OWNER |
EX-2090 Rahman 2010 | Dec 3, 2024 | EXHIBIT | PATENT OWNER |
EX-2091 Acheampong 2002 | Dec 3, 2024 | EXHIBIT | PATENT OWNER |
EX-2093 Prelim Injun Depo Tr. Daniel Gil, Dec. 31, 2023-Condensed | Dec 3, 2024 | EXHIBIT | PATENT OWNER |
EX-2094 Belmonte 2004 | Dec 3, 2024 | EXHIBIT | PATENT OWNER |
EX-2095 Bausch Press Release (2002) | Dec 3, 2024 | EXHIBIT | PATENT OWNER |
EX-2096 U.S. Patent No. 3,890,319 (Pfizer) | Dec 3, 2024 | EXHIBIT | PATENT OWNER |
EX-2098 OTC Drug Review Process _ OTC Drug Monographs _ FDA | Dec 3, 2024 | EXHIBIT | PATENT OWNER |
EX-2099 Drugs@FDA Alphagan 0.5% | Dec 3, 2024 | EXHIBIT | PATENT OWNER |
EX-2100 IPR2024-00467 Depo Tr. Reza Dana, M.D., MSc, MPH - Mini | Dec 3, 2024 | EXHIBIT | PATENT OWNER |
EX-2101 Uretmen 2003 | Dec 3, 2024 | EXHIBIT | PATENT OWNER |
EX-2102 Zhan 1997 | Dec 3, 2024 | EXHIBIT | PATENT OWNER |
EXPUNGED | Dec 3, 2024 | EXHIBIT | PATENT OWNER |
EX-2104 11-100-0015 Clinical Study Report Excerpt PUBLIC | Dec 3, 2024 | EXHIBIT | PATENT OWNER |
EX-2105 13-100-0005 Clinical Study Report Excerpt PUBLIC | Dec 3, 2024 | EXHIBIT | PATENT OWNER |
EX-2106 Enhancing the Management of Red Eye | Dec 3, 2024 | EXHIBIT | PATENT OWNER |
EX-2107 Alphagan 0.2% Leaflet | Dec 3, 2024 | EXHIBIT | PATENT OWNER |
EX-2108 Alphagan 0.2% Monograph | Dec 3, 2024 | EXHIBIT | PATENT OWNER |
EX-2126 (Perloff and Carlton)_Part 1 of 2 | Dec 3, 2024 | EXHIBIT | PATENT OWNER |
EX-2126 (Perloff and Carlton)_Part 2 of 2 | Dec 3, 2024 | EXHIBIT | PATENT OWNER |
EX-2127 (Samuelson and Nordhause) updated_Part 1 of 2 | Dec 3, 2024 | EXHIBIT | PATENT OWNER |
EX-2127 (Samuelson and Nordhause) updated_Part 2 of 2 | Dec 3, 2024 | EXHIBIT | PATENT OWNER |
EX-2128 (Spiegel and Gerber) | Dec 3, 2024 | EXHIBIT | PATENT OWNER |
EX-2129 Thomas 2011 | Dec 3, 2024 | EXHIBIT | PATENT OWNER |
EX-2130 (Thomas and Melton) 2016 | Dec 3, 2024 | EXHIBIT | PATENT OWNER |
EX-2131 BAU-LUM00063901 Test | Dec 3, 2024 | EXHIBIT | PATENT OWNER |
EX-2132 LUM.0205.USA.21-LUMIFY - An Advance in Redness Relief (Under Seal) | Dec 3, 2024 | EXHIBIT | PATENT OWNER |
EX-2132 LUM.0205.USA.21-LUMIFY_Advance in Redness (Public) | Dec 3, 2024 | EXHIBIT | PATENT OWNER |
EX-2133 LUM.1827.USA.21-ECP Detail Aid - PRC Aprvd | Dec 3, 2024 | EXHIBIT | PATENT OWNER |
EX-2135 LUMIFY LEGAL DATA JULY 2022 (Under Seal) | Dec 3, 2024 | EXHIBIT | PATENT OWNER |
EX-2135 LUMIFY LEGAL DATA JULY 2022 (Public) | Dec 3, 2024 | EXHIBIT | PATENT OWNER |
EX-2136 LUMIFY LEGAL DATA POS JULY 2022 (Under Seal) | Dec 3, 2024 | EXHIBIT | PATENT OWNER |
EX-2136 LUMIFY LEGAL DATA POS JULY 2022 (Public) | Dec 3, 2024 | EXHIBIT | PATENT OWNER |
EX-2137 (Visine Supp Approval) | Dec 3, 2024 | EXHIBIT | PATENT OWNER |
EX-2138 (Lumify Apr 2019 Supp) | Dec 3, 2024 | EXHIBIT | PATENT OWNER |
EX-2139 (Lumify Feb 2019 Supp) | Dec 3, 2024 | EXHIBIT | PATENT OWNER |
EX-2140 (Lumify Mar 2020 Supp) | Dec 3, 2024 | EXHIBIT | PATENT OWNER |
EX-2141 (Lumify Nov 2021 Supp) | Dec 3, 2024 | EXHIBIT | PATENT OWNER |
EX-2142 (Lumify Sep 2020 Supp) | Dec 3, 2024 | EXHIBIT | PATENT OWNER |
EX-2143 (Lumify NDA Approval) | Dec 3, 2024 | EXHIBIT | PATENT OWNER |
EX-2144 (Lumify NDA Summary) | Dec 3, 2024 | EXHIBIT | PATENT OWNER |
EX-2145 (2022 Q1 10Q) | Dec 3, 2024 | EXHIBIT | PATENT OWNER |
EX-2146 (2022 Q1 Presentation) | Dec 3, 2024 | EXHIBIT | PATENT OWNER |
EX-2147 (Bausch Jan 2022 S-1)_Part 1 of 3 | Dec 3, 2024 | EXHIBIT | PATENT OWNER |
EX-2147 (Bausch Jan 2022 S-1)_Part 2 of 3 | Dec 3, 2024 | EXHIBIT | PATENT OWNER |
EX-2147 (Bausch Jan 2022 S-1)_Part 3 of 3 | Dec 3, 2024 | EXHIBIT | PATENT OWNER |
EX-2109 Dillon Pena_ LUMIFY Lover 2021 | Dec 3, 2024 | EXHIBIT | PATENT OWNER |
EX-2110 Schuman 1997 | Dec 3, 2024 | EXHIBIT | PATENT OWNER |
EX-2111 Alphagan 0.5%, 0.2%, 0.15 - Medical Review | Dec 3, 2024 | EXHIBIT | PATENT OWNER |
EX-2113 Kusari 2011 | Dec 3, 2024 | EXHIBIT | PATENT OWNER |
EX-2114 Woldmussie 2001 | Dec 3, 2024 | EXHIBIT | PATENT OWNER |
EX-2115 Lambert 2011 | Dec 3, 2024 | EXHIBIT | PATENT OWNER |
EX-2116 Lai | Dec 3, 2024 | EXHIBIT | PATENT OWNER |
EX-2117 Gil 2009 | Dec 3, 2024 | EXHIBIT | PATENT OWNER |
EX-2118 AU 2002254265 | Dec 3, 2024 | EXHIBIT | PATENT OWNER |
EX-2119 Alphagan P Monograph | Dec 3, 2024 | EXHIBIT | PATENT OWNER |
EX-2120 Flammer 2002 | Dec 3, 2024 | EXHIBIT | PATENT OWNER |
EX-2121 Bagwell 2005 | Dec 3, 2024 | EXHIBIT | PATENT OWNER |
EX-2122 Congressional Budget Office Dec 2009 | Dec 3, 2024 | EXHIBIT | PATENT OWNER |
EX-2123 Ching and Ishihara 2012 | Dec 3, 2024 | EXHIBIT | PATENT OWNER |
EX-2124 Gonzalez et al 2014 | Dec 3, 2024 | EXHIBIT | PATENT OWNER |
EX-2125 IRI Report New Product Pacesetters May 2020 | Dec 3, 2024 | EXHIBIT | PATENT OWNER |
EX-2046 NDA 208144, Section 2.3.P.1.1 (Under Seal) | Dec 3, 2024 | EXHIBIT | PATENT OWNER |
EX-2063 LUMIFY September 2024 Business Update (Under Seal) | Dec 3, 2024 | EXHIBIT | PATENT OWNER |
EX-2069 Lumify ECP A&U Report 2020 (Under Seal) | Dec 3, 2024 | EXHIBIT | PATENT OWNER |
EX-2070 Lumify ECP A&U Report (Under Seal) | Dec 3, 2024 | EXHIBIT | PATENT OWNER |
EX-2072 LUMIFY PnL 93024 format (Under Seal) | Dec 3, 2024 | EXHIBIT | PATENT OWNER |
EX-2074 LUMIFY INCREMENTAL TO EYE CARE & RED RELIVERS CAT. (Under Seal) | Dec 3, 2024 | EXHIBIT | PATENT OWNER |
EX-2075 LUMIFY INCREMENTALITY 09-08-24 (Under Seal) | Dec 3, 2024 | EXHIBIT | PATENT OWNER |
EX-2077 LUMIFY LEGAL DATA OCTOBER 2024 (Under Seal) | Dec 3, 2024 | EXHIBIT | PATENT OWNER |
EX-2078 LUMIFY LEGAL DATA POS OCTOBER 2024 format (Under Seal) | Dec 3, 2024 | EXHIBIT | PATENT OWNER |
EX-2103 10-100-0008 Clinical Study Report Excerpted (Under Seal) | Dec 3, 2024 | EXHIBIT | PATENT OWNER |
EX-2104 11-100-0015 Clinical Study Report Excerpted (Under Seal) | Dec 3, 2024 | EXHIBIT | PATENT OWNER |
EX-2105 13-100-0005 Clinical Study Report Excerpted (Under Seal) | Dec 3, 2024 | EXHIBIT | PATENT OWNER |
EX-2066 Science Behind LUMIFY Redness Reliever Eye Drops test | Dec 3, 2024 | EXHIBIT | PATENT OWNER |
EX-2226 Declaration of Robert O. Williams III Ph.D (600 IPR - Under Seal) | Dec 3, 2024 | EXHIBIT | PATENT OWNER |
EX-2226 Declaration of Robert O. Williams III Ph.D (600 IPR)_Redacted) | Dec 3, 2024 | EXHIBIT | PATENT OWNER |
EX-2229 Declaration of John C. Jarosz (600 IPR - Under Seal) | Dec 3, 2024 | EXHIBIT | PATENT OWNER |
EX-2229 Declaration of John C. Jarosz (600 IPR - Public) | Dec 3, 2024 | EXHIBIT | PATENT OWNER |
EX-2230_Declaration of John Ferris (600 Patent - Public) | Dec 3, 2024 | EXHIBIT | PATENT OWNER |
Patent Owner's Motion to Seal and Entry of Stipulated Proposed Protective Order | Dec 3, 2024 | PAPER | PATENT OWNER |
Patent Owner's Response (Under Seal) | Dec 3, 2024 | PAPER | PATENT OWNER |
Patent Owner's Response (Public) | Dec 3, 2024 | PAPER | PATENT OWNER |
EX-2223 Declaration of Robert J. Noecker M.D. MBA (600 IPR - Under Seal) | Dec 3, 2024 | EXHIBIT | PATENT OWNER |
EX-2223 Declaration of Robert J. Noecker M.D. MBA (600 IPR - Public) | Dec 3, 2024 | EXHIBIT | PATENT OWNER |
Patent Owner's Third Updated Exhibit List | Dec 3, 2024 | PAPER | PATENT OWNER |
EX-2216 3q24-bausch-lomb-earnings-presentation (replacement) | Dec 3, 2024 | EXHIBIT | PATENT OWNER |
EX-2103_10-100-0008 Clinical Study Report (Public) replacement | Dec 3, 2024 | EXHIBIT | PATENT OWNER |
Patent Owner's Updated Mandatory Notices | Oct 21, 2024 | PAPER | PATENT OWNER |
Patent Owner's Notice of Deposition of John C. Galanis, MD, FACS | Oct 15, 2024 | PAPER | PATENT OWNER |
Patent Owner's Notice of Deposition of Paul A. Laskar, Ph.D. | Oct 15, 2024 | PAPER | PATENT OWNER |
Patent Owner's Notice of Deposition of Reza Dana MD, MSc, MPH | Oct 15, 2024 | PAPER | PATENT OWNER |
Joint Stipulation to Change Due Dates 1, 2, and 3 | Oct 9, 2024 | PAPER | PATENT OWNER |
Petitioners' Objections to Evidence Filed with Patent Owner's Preliminary Response | Sep 24, 2024 | PAPER | PETITIONER |
Decision Granting Institution of Inter Partes Review | Sep 10, 2024 | PAPER | BOARD |
Scheduling Order | Sep 10, 2024 | PAPER | BOARD |
Patent Owner's Second Updated Exhibit List | Sep 4, 2024 | PAPER | PATENT OWNER |
Exhibit 2035 | Sep 4, 2024 | EXHIBIT | PATENT OWNER |
Petitioner's Reply to Patent Owner's Preliminary Response | Jul 29, 2024 | PAPER | PETITIONER |
Patent Owner's Sur-Reply to Petitioner's Reply to Patent Owner's Preliminary Response | Jul 29, 2024 | PAPER | PATENT OWNER |
Exhibit 2018 | Jul 29, 2024 | EXHIBIT | PATENT OWNER |
Patent Owner's Updated Exhibit List | Jul 29, 2024 | PAPER | PATENT OWNER |
Exhibit 3001 | Jul 22, 2024 | EXHIBIT | BOARD |
Patent Owner's Preliminary Response | Jun 17, 2024 | PAPER | PATENT OWNER |
Patent Owner's Exhibit List | Jun 17, 2024 | PAPER | PATENT OWNER |
Exhibit 2001 | Jun 17, 2024 | EXHIBIT | PATENT OWNER |
Exhibit 2002 | Jun 17, 2024 | EXHIBIT | PATENT OWNER |
Exhibit 2003 | Jun 17, 2024 | EXHIBIT | PATENT OWNER |
Exhibit 2004 | Jun 17, 2024 | EXHIBIT | PATENT OWNER |
Exhibit 2005 | Jun 17, 2024 | EXHIBIT | PATENT OWNER |
Exhibit 2006 | Jun 17, 2024 | EXHIBIT | PATENT OWNER |
Exhibit 2007 | Jun 17, 2024 | EXHIBIT | PATENT OWNER |
Exhibit 2008 | Jun 17, 2024 | EXHIBIT | PATENT OWNER |
Exhibit 2009 | Jun 17, 2024 | EXHIBIT | PATENT OWNER |
Exhibit 2010 | Jun 17, 2024 | EXHIBIT | PATENT OWNER |
Exhibit 2011 | Jun 17, 2024 | EXHIBIT | PATENT OWNER |
Exhibit 2012 | Jun 17, 2024 | EXHIBIT | PATENT OWNER |
Exhibit 2013 | Jun 17, 2024 | EXHIBIT | PATENT OWNER |
Exhibit 2014 | Jun 17, 2024 | EXHIBIT | PATENT OWNER |
Exhibit 2015 | Jun 17, 2024 | EXHIBIT | PATENT OWNER |
Exhibit 2016 | Jun 17, 2024 | EXHIBIT | PATENT OWNER |
Exhibit 2017 | Jun 17, 2024 | EXHIBIT | PATENT OWNER |
Exhibit 2019 | Jun 17, 2024 | EXHIBIT | PATENT OWNER |
Exhibit 2020 | Jun 17, 2024 | EXHIBIT | PATENT OWNER |
Exhibit 2021 | Jun 17, 2024 | EXHIBIT | PATENT OWNER |
Exhibit 2022 Part 1 | Jun 17, 2024 | EXHIBIT | PATENT OWNER |
Exhibit 2022 Part 2 | Jun 17, 2024 | EXHIBIT | PATENT OWNER |
Exhibit 2023 | Jun 17, 2024 | EXHIBIT | PATENT OWNER |
Exhibit 2024 | Jun 17, 2024 | EXHIBIT | PATENT OWNER |
Exhibit 2025 | Jun 17, 2024 | EXHIBIT | PATENT OWNER |
Exhibit 2026 | Jun 17, 2024 | EXHIBIT | PATENT OWNER |
Exhibit 2027 | Jun 17, 2024 | EXHIBIT | PATENT OWNER |
Exhibit 2028 | Jun 17, 2024 | EXHIBIT | PATENT OWNER |
Exhibit 2029 | Jun 17, 2024 | EXHIBIT | PATENT OWNER |
Exhibit 2030 | Jun 17, 2024 | EXHIBIT | PATENT OWNER |
Exhibit 2032 | Jun 17, 2024 | EXHIBIT | PATENT OWNER |
Exhibit 2033 | Jun 17, 2024 | EXHIBIT | PATENT OWNER |
Exhibit 2034 | Jun 17, 2024 | EXHIBIT | PATENT OWNER |
Notice: Notice filing date accorded | Mar 15, 2024 | PAPER | BOARD |
Notice : Mandatory Notice | Mar 12, 2024 | PAPER | PATENT OWNER |
Notice : Power of Attorney | Mar 12, 2024 | PAPER | PATENT OWNER |
Exhibit 1001 | Feb 21, 2024 | EXHIBIT | PETITIONER |
Exhibit 1002 | Feb 21, 2024 | EXHIBIT | PETITIONER |
Exhibit 1003 | Feb 21, 2024 | EXHIBIT | PETITIONER |
Exhibit 1004 | Feb 21, 2024 | EXHIBIT | PETITIONER |
Exhibit 1006 | Feb 21, 2024 | EXHIBIT | PETITIONER |
Exhibit 1007 | Feb 21, 2024 | EXHIBIT | PETITIONER |
Exhibit 1008 | Feb 21, 2024 | EXHIBIT | PETITIONER |
Exhibit 1009, Part 1 of 2 | Feb 21, 2024 | EXHIBIT | PETITIONER |
Exhibit 1009, Part 2 of 2 | Feb 21, 2024 | EXHIBIT | PETITIONER |
Exhibit 1010, Part 1 of 2 | Feb 21, 2024 | EXHIBIT | PETITIONER |
Exhibit 1010, Part 2 of 2 | Feb 21, 2024 | EXHIBIT | PETITIONER |
Exhibit 1016 | Feb 21, 2024 | EXHIBIT | PETITIONER |
Exhibit 1020 | Feb 21, 2024 | EXHIBIT | PETITIONER |
Exhibit 1021 | Feb 21, 2024 | EXHIBIT | PETITIONER |
Exhibit 1022 | Feb 21, 2024 | EXHIBIT | PETITIONER |
Exhibit 1023 | Feb 21, 2024 | EXHIBIT | PETITIONER |
Exhibit 1024 | Feb 21, 2024 | EXHIBIT | PETITIONER |
Exhibit 1025 | Feb 21, 2024 | EXHIBIT | PETITIONER |
Exhibit 1026 | Feb 21, 2024 | EXHIBIT | PETITIONER |
Exhibit 1027 | Feb 21, 2024 | EXHIBIT | PETITIONER |
Exhibit 1028 | Feb 21, 2024 | EXHIBIT | PETITIONER |
Exhibit 1029 | Feb 21, 2024 | EXHIBIT | PETITIONER |
Exhibit 1030 | Feb 21, 2024 | EXHIBIT | PETITIONER |
Exhibit 1031 | Feb 21, 2024 | EXHIBIT | PETITIONER |
Exhibit 1032 | Feb 21, 2024 | EXHIBIT | PETITIONER |
Exhibit 1034 | Feb 21, 2024 | EXHIBIT | PETITIONER |
Exhibit 1035 | Feb 21, 2024 | EXHIBIT | PETITIONER |
Exhibit 1040, Part 1 of 5 | Feb 21, 2024 | EXHIBIT | PETITIONER |
Exhibit 1040, Part 2 of 5 | Feb 21, 2024 | EXHIBIT | PETITIONER |
Exhibit 1040, Part 3 of 5 | Feb 21, 2024 | EXHIBIT | PETITIONER |
Exhibit 1040, Part 4 of 5 | Feb 21, 2024 | EXHIBIT | PETITIONER |
Exhibit 1040, Part 5 of 5 | Feb 21, 2024 | EXHIBIT | PETITIONER |
Exhibit 1042 | Feb 21, 2024 | EXHIBIT | PETITIONER |
Exhibit 1043 | Feb 21, 2024 | EXHIBIT | PETITIONER |
Exhibit 1046 | Feb 21, 2024 | EXHIBIT | PETITIONER |
Exhibit 1049, Part 1 of 5 | Feb 21, 2024 | EXHIBIT | PETITIONER |
Exhibit 1049, Part 2 of 5 | Feb 21, 2024 | EXHIBIT | PETITIONER |
Exhibit 1049, Part 3 of 5 | Feb 21, 2024 | EXHIBIT | PETITIONER |
Exhibit 1049, Part 4 of 5 | Feb 21, 2024 | EXHIBIT | PETITIONER |
Exhibit 1049, Part 5 of 5 | Feb 21, 2024 | EXHIBIT | PETITIONER |
Exhibit 1050 | Feb 21, 2024 | EXHIBIT | PETITIONER |
Exhibit 1041 | Feb 21, 2024 | EXHIBIT | PETITIONER |
Exhibit 1051 | Feb 21, 2024 | EXHIBIT | PETITIONER |
Exhibit 1052 | Feb 21, 2024 | EXHIBIT | PETITIONER |
Exhibit 1055 | Feb 21, 2024 | EXHIBIT | PETITIONER |
Exhibit 1056 | Feb 21, 2024 | EXHIBIT | PETITIONER |
Exhibit 1057 | Feb 21, 2024 | EXHIBIT | PETITIONER |
Exhibit 1061, Part 1 of 2 | Feb 21, 2024 | EXHIBIT | PETITIONER |
Exhibit 1061, Part 2 of 2 | Feb 21, 2024 | EXHIBIT | PETITIONER |
Exhibit 1062 | Feb 21, 2024 | EXHIBIT | PETITIONER |
Exhibit 1063 | Feb 21, 2024 | EXHIBIT | PETITIONER |
Exhibit 1064 | Feb 21, 2024 | EXHIBIT | PETITIONER |
Exhibit 1066 | Feb 21, 2024 | EXHIBIT | PETITIONER |
Exhibit 1067 | Feb 21, 2024 | EXHIBIT | PETITIONER |
Exhibit 1068 | Feb 21, 2024 | EXHIBIT | PETITIONER |
Exhibit 1071 | Feb 21, 2024 | EXHIBIT | PETITIONER |
Exhibit 1073 | Feb 21, 2024 | EXHIBIT | PETITIONER |
Exhibit 1074 | Feb 21, 2024 | EXHIBIT | PETITIONER |
Exhibit 1075, Part 1 of 3 | Feb 21, 2024 | EXHIBIT | PETITIONER |
Exhibit 1075, Part 2 of 3 | Feb 21, 2024 | EXHIBIT | PETITIONER |
Exhibit 1075, Part 3 of 3 | Feb 21, 2024 | EXHIBIT | PETITIONER |
Exhibit 1112 | Feb 21, 2024 | EXHIBIT | PETITIONER |
Exhibit 1130 | Feb 21, 2024 | EXHIBIT | PETITIONER |
Exhibit 1131 | Feb 21, 2024 | EXHIBIT | PETITIONER |
Exhibit 1132 | Feb 21, 2024 | EXHIBIT | PETITIONER |
Exhibit 1134 | Feb 21, 2024 | EXHIBIT | PETITIONER |
Exhibit 1135 | Feb 21, 2024 | EXHIBIT | PETITIONER |
Exhibit 1136 | Feb 21, 2024 | EXHIBIT | PETITIONER |
Exhibit 1137 | Feb 21, 2024 | EXHIBIT | PETITIONER |
Exhibit 1138 | Feb 21, 2024 | EXHIBIT | PETITIONER |
Exhibit 1146 | Feb 21, 2024 | EXHIBIT | PETITIONER |
Exhibit 1148 | Feb 21, 2024 | EXHIBIT | PETITIONER |
Exhibit 1149 | Feb 21, 2024 | EXHIBIT | PETITIONER |
Exhibit 1150 | Feb 21, 2024 | EXHIBIT | PETITIONER |
Exhibit 1151 | Feb 21, 2024 | EXHIBIT | PETITIONER |
Exhibit 1152 | Feb 21, 2024 | EXHIBIT | PETITIONER |
Exhibit 1153 | Feb 21, 2024 | EXHIBIT | PETITIONER |
Exhibit 1154 | Feb 21, 2024 | EXHIBIT | PETITIONER |
Exhibit 1155 | Feb 21, 2024 | EXHIBIT | PETITIONER |
Exhibit 1156 | Feb 21, 2024 | EXHIBIT | PETITIONER |
Exhibit 1157 | Feb 21, 2024 | EXHIBIT | PETITIONER |
Exhibit 1158 | Feb 21, 2024 | EXHIBIT | PETITIONER |
Exhibit 1159 | Feb 21, 2024 | EXHIBIT | PETITIONER |
Exhibit 1160 | Feb 21, 2024 | EXHIBIT | PETITIONER |
Exhibit 1161 | Feb 21, 2024 | EXHIBIT | PETITIONER |
Exhibit 1165 | Feb 21, 2024 | EXHIBIT | PETITIONER |
Exhibit 1166 | Feb 21, 2024 | EXHIBIT | PETITIONER |
Exhibit 1065 | Feb 21, 2024 | EXHIBIT | PETITIONER |
Exhibit 1142 | Feb 21, 2024 | EXHIBIT | PETITIONER |
Exhibit 1143 | Feb 21, 2024 | EXHIBIT | PETITIONER |
Notice : Power of Attorney | Feb 21, 2024 | PAPER | PETITIONER |
Petition for Inter Partes Review of U.S. Patent No. 11,596,600 | Feb 21, 2024 | PAPER | PETITIONER |
Exhibit 1012 | Feb 21, 2024 | EXHIBIT | PETITIONER |
Exhibit 1013 | Feb 21, 2024 | EXHIBIT | PETITIONER |
Exhibit 1014 | Feb 21, 2024 | EXHIBIT | PETITIONER |